FG Financial Group Inc. (FGF)
NASDAQ: FGF
· Real-Time Price · USD
5.87
-0.13 (-2.17%)
At close: Oct 03, 2025, 3:57 PM
5.82
-0.85%
After-hours: Oct 03, 2025, 04:11 PM EDT
-2.17% (1D)
| Bid | 5.82 |
| Market Cap | 7.47M |
| Revenue (ttm) | 11.89M |
| Net Income (ttm) | 4.77M |
| EPS (ttm) | -13.03 |
| PE Ratio (ttm) | -0.45 |
| Forward PE | 0.44 |
| Analyst | n/a |
| Dividends | n/a |
| Ask | 6.34 |
| Volume | 496,649 |
| Avg. Volume (20D) | 197,733.5 |
| Open | 6.00 |
| Previous Close | 6.00 |
| Day's Range | 5.72 - 6.10 |
| 52-Week Range | 5.42 - 41.25 |
| Beta | 0.94 |
| Ex-Dividend Date | n/a |
10 months ago
+15.93%
Fundamental Global shares are trading higher after...
Unlock content with
Pro Subscription
11 months ago
+24.3%
Fundamental Global shares are trading higher. The company announced a 1-for-25 reverse stock split.
4 months ago · seekingalpha.com
Akero: FGF21 Advancement For MASH Targeting Presses On With Key DevelopmentsAkero Therapeutics' efruxifermin shows strong potential in MASH, especially compensated cirrhosis, with positive 96-week phase 2b data published in NEJM. The SYNCHRONY phase 3 program targets a broad ...